Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galantamine”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01190761
What this trial is testing

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions

Who this might be right for
Healthy
Actavis Inc. 24
Post-approval studies (Phase 4)Ended earlyNCT00232349
What this trial is testing

Efficacy of Galantamine to Treat Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder
Seattle Institute for Biomedical and Clinical Research 21
Large-scale testing (Phase 3)Study completedNCT00000172
What this trial is testing

Evaluation of Galantamine in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen, LP
Early research (Phase 1)Study completedNCT01039194
What this trial is testing

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 18
Post-approval studies (Phase 4)Ended earlyNCT01181921
What this trial is testing

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen-Cilag, S.A. 1
Testing effectiveness (Phase 2)Ended earlyNCT02234752
What this trial is testing

Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheppard Pratt Health System 3
Large-scale testing (Phase 3)Study completedNCT00566735
What this trial is testing

The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning

Who this might be right for
Major DepressionBipolar DepressionSchizoaffective Disorder
Massachusetts General Hospital 39
Large-scale testing (Phase 3)Study completedNCT00230997
What this trial is testing

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

Who this might be right for
Lewy Body Disease
Neurological Research Center 50
Large-scale testing (Phase 3)Study completedNCT00252603
What this trial is testing

Galantamine Versus Placebo in Childhood Autism

Who this might be right for
AutismChildhood Autism
University of Medicine and Dentistry of New Jersey 20
Not applicableStudy completedNCT00283725
What this trial is testing

Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer's Disease
Ortho-McNeil Neurologics, Inc. 573
Large-scale testing (Phase 3)Study completedNCT00035191
What this trial is testing

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

Who this might be right for
Dementia, Vascular
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 254
Not applicableStudy completedNCT00297414
What this trial is testing

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Who this might be right for
Mild Cognitive Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,083
Large-scale testing (Phase 3)Study completedNCT00253188
What this trial is testing

The Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 653
Not applicableUnknownNCT00211588
What this trial is testing

Galantamine Executive Function in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Memorial Hospital of Rhode Island 90
Post-approval studies (Phase 4)Study completedNCT01529619
What this trial is testing

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT01100775
What this trial is testing

Effects of Galantamine on Cognition

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 12
Large-scale testing (Phase 3)Study completedNCT00216593
What this trial is testing

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

Who this might be right for
DementiaAlzheimer Disease
Janssen Pharmaceutica N.V., Belgium 415
Very early researchStudy completedNCT03547622
What this trial is testing

Galantamine and CBT4CBT Pilot to Prevent Relapse.

Who this might be right for
Methadone or Buprenorphine Detoxoxification
Yale University 6
Testing effectiveness (Phase 2)Study completedNCT01508494
What this trial is testing

Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment

Who this might be right for
StrokeCognitive Impairment
Institut National de la Santé Et de la Recherche Médicale, France 47
Not applicableStudy completedNCT01734395
What this trial is testing

Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Korea, Ltd., Korea 1,882
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation